PAF-ACETHER SPECIFIC BINDING-SITES .2. DESIGN OF SPECIFIC ANTAGONISTS

被引:161
作者
BRAQUET, P [1 ]
GODFROID, JJ [1 ]
机构
[1] UNIV PARIS 07,PHARMACOCHIM MOLEC LAB,F-75251 PARIS 05,FRANCE
关键词
D O I
10.1016/0165-6147(86)90401-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:397 / 403
页数:7
相关论文
共 27 条
[1]   THE EFFECT OF 1-O-ALKYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE (PAF-ACETHER) ON THE ARTERIAL-WALL [J].
BOURGAIN, RH ;
MAES, L ;
BRAQUET, P ;
ANDRIES, R ;
TOUQUI, L ;
BRAQUET, M .
PROSTAGLANDINS, 1985, 30 (02) :185-197
[2]  
BRAQUET P, 1985, LANCET, V1, P1501
[3]  
BRAQUET P, 1986, ACTUAL CHIM THER, V13, P237
[4]  
BRAQUET P, PLATELET ACTIVATING
[5]  
BRUIJNZEEL PLB, PHARM RES COMMUN
[6]   INHIBITION BY SULPHINPYRAZONE OF THE PLATELET-DEPENDENT BRONCHOCONSTRICTION DUE TO PLATELET-ACTIVATING FACTOR (PAF-ACETHER) IN THE GUINEA-PIG [J].
CHIGNARD, M ;
WAL, F ;
LEFORT, J ;
VARGAFTIG, BB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 78 (01) :71-79
[7]  
CIRINO M, 1985, NEW MEDIATORS TISSUE
[8]  
DESQUAND S, EUR J PHARM
[9]   PLATELET ACTIVATING FACTOR (PAF) INVOLVEMENT IN ENDOTOXIN-INDUCED HYPOTENSION IN RATS - STUDIES WITH PAF-RECEPTOR ANTAGONIST KADSURENONE [J].
DOEBBER, TW ;
WU, MS ;
ROBBINS, JC ;
CHOY, BM ;
CHANG, MN ;
SHEN, TY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 127 (03) :799-808
[10]  
FOEGH M, 1985, ADV PROSTAGLANDIN TH, V15